← Back to screener

Axogen, Inc. AXGN

Rank #2335 · Nasdaq · $2.6B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
23.9
P/E
-120.9
P/B
25.99
ROE
-21.5%
Op. Margin
-13.5%
Debt Ratio
99%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E -120.9x, P/B 25.99x. Ranks in the top 79% of the universe.

Profitability ★☆☆☆☆
Poor

ROE -21.5%. Ranks in the top 81% of the universe.

Safety ★★★☆☆
Good

Debt ratio 99%. Ranks in the top 39% of the universe.

Growth ★★★★☆
Good

Revenue growth of 14.7% year over year. Ranks in the top 26% of the universe.

Growth is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.0B$-0.0B$-0.0B$-0.0B-149.2-63
2012$0.0B$-0.0B$-0.0B$-0.0B-143.7-24
2013$0.0B$-0.0B$-0.0B$0.0B-101.4380
2014$0.0B$-0.0B$-0.0B$-0.0B-87.6-974
2015$0.0B$-0.0B$-0.0B$0.0B-58.320234
2016$0.0B$-0.0B$-0.0B$-0.0B-33.9-253
2017$0.0B$-0.0B$-0.0B$-0.0B-33.9-280
2018$0.0B$-0.0B$-0.0B$0.0B-19.8411
2019$0.1B$-0.0B$-0.0B$0.0B-13.288
2020$0.1B$-0.0B$-0.0B$0.0B-24.489
2021$0.1B$-0.0B$-0.0B$0.1B-29.453
2022$0.1B$-0.0B$-0.0B$0.1B-20.672
2023$0.1B$-0.0B$-0.0B$0.1B-20.077
2024$0.1B$-0.0B$-0.0B$0.1B-21.490
2025$0.2B$-0.0B$-0.0B$0.1B-13.599

← See the full screener